chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vaccination site pain
Clinical narrative: Pain at injection site; headache; muscle pain; chills; joint pain; tiredness; fever; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 43-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: not provided), via intramuscular route of administration, on 28Dec2020 at 09:15 AM (at the age of 43 years old) as a single dose in the right arm for COVID-19 immunization. Relevant medical history was none. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. Concomitant medication were not provided. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 28Dec2020, at 11:30 PM, the patient experienced pain at injection site, headache, muscle pain, chills, joint pain, fever, tiredness and nausea. No treatment was received for the events pain at injection site, headache, muscle pain, chills, joint pain, fever, tiredness and nausea. The outcome of the events pain at injection site, headache, muscle pain, chills, joint pain, fever, tiredness and nausea was recovered on an unspecified date in Dec2020. Since the vaccination, the patient had not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Fatigue; Nausea; Headache; Abdominal pain; Muscle soreness (spot of injection, it is better now); This is a spontaneous report from a contactable other healthcare professional, the patient. A 29-year-old female received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL0140), via an unspecified route of administration on 28Dec2020 at 04:00 PM (at the age of 29-years-old) as a single dose in the left arm for COVID-19 vaccination. The patient had no relevant medical history. The patient did not have any allergies to medications, food, or other products. The patient was not pregnant at the time of vaccination. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. The patient's concomitant medications in the past two weeks included bupropion hydrochloride ER 200 mg and ritual vitamins. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 29Dec2020, the patient experienced fatigue, nausea, headache, abdominal pain and muscle soreness (spot of injection is better now). The patient did not receive any treatment for the events. The clinical outcome of fatigue, nausea, headache, abdominal pain and muscle soreness was recovering.  It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Caller received COVID vaccine on the 18th then tested positive on the 24th; Caller received COVID vaccine on the 18th then tested positive on the 24th; This is a spontaneous report from a contactable healthcare professional. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 18Dec2020 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was reported that the patient received COVID 'vaccine on the 18th then tested positive on the 24th'. The reporter mentioned that a friend who works for Pfizer told her to call and report. Clinical outcome of the events was unknown.  Information on batch/lot number was requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event of positive for corona virus infection for the lack of efficacy of the vaccine. However, based on the mechanism of action of the vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the short duration of 6 days since the vaccine first dose is given.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Swelling of my arm and hand; Swelling of my arm and hand; This is a spontaneous report from a contactable nurse, the patient.  A 58-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot number: EL0140), via an unspecified route of administration, on 30Dec2020 at 04:30 PM (at the age of 58-years-old) as a single dose for COVID-19 vaccination. The facility where COVID-19 vaccine was administered was at a hospital and anatomically located on the right arm. Medical history included Allergy induced asthma. The patient was not pregnant at the time of vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included montelukast sodium (SINGULAIR) (MANUFACTURER UNKNOWN), progesterone (MANUFACTURER UNKNOWN), estradiol (ESTROGEN) (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took Sulfa (MANUFACTURER UNKNOWN) and Keflex (MANUFACTURER UNKNOWN), from unknown dates to unknown dates for unknown indications and experienced allergy. On 31Dec2020, the patient reported "Swelling of my arm and hand." The patient did not receive any treatment for the events. The clinical outcome of the events swelling of my arm and hand was recovering/resolving.  It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Cough, Dizziness, Dyspnoea, Headache
Clinical narrative: Headache; I got small fever like 99.9; Muscle pain; Feeling unwell; Difficult breathing just a little bit just like a cough a little small cough; Difficult breathing just a little bit just like a cough a little small cough; Dizziness; Cold; This is a spontaneous report from a contactable consumer (patient). A 64-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on 24Dec2020 at single dose for COVID-19 immunization. Medical history included diabetes, high blood pressure, and cholesterol. Concomitant medications included diabetes medication, medications for high blood pressure and for cholesterol. The patient stated that he got the Pfizer vaccine on Christmas eve that would be the 24th and today (30Dec2020) he was getting just small things like headache, fever (small fever like 99.9), muscle pain, feeling unwell, difficult breathing just a little bit just like a cough a little small cough, dizziness, and probably just a cold. There was no injection swelling, fast heartbeat, and rash. He doesn't know if he should go get tested for COVID or not because he just took the shot. The patient stated that he got to get the next dose of the vaccine on the 14th of January. The outcome of the events was unknown.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Nasopharyngitis, Pyrexia
Clinical narrative: Headache; I got small fever like 99.9; Muscle pain; Feeling unwell; Difficult breathing just a little bit just like a cough a little small cough; Difficult breathing just a little bit just like a cough a little small cough; Dizziness; Cold; This is a spontaneous report from a contactable consumer (patient). A 64-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on 24Dec2020 at single dose for COVID-19 immunization. Medical history included diabetes, high blood pressure, and cholesterol. Concomitant medications included diabetes medication, medications for high blood pressure and for cholesterol. The patient stated that he got the Pfizer vaccine on Christmas eve that would be the 24th and today (30Dec2020) he was getting just small things like headache, fever (small fever like 99.9), muscle pain, feeling unwell, difficult breathing just a little bit just like a cough a little small cough, dizziness, and probably just a cold. There was no injection swelling, fast heartbeat, and rash. He doesn't know if he should go get tested for COVID or not because he just took the shot. The patient stated that he got to get the next dose of the vaccine on the 14th of January. The outcome of the events was unknown.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea
Clinical narrative: Severe headache, fatigue, nausea; Severe headache, fatigue, nausea; Severe headache, fatigue, nausea; This is a spontaneous report from a non-contactable nurse, reporting for the patient.  A 23-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot number: EJ1685), via intramuscular route of administration, on 30Dec2020 at 12:45 AM (at the age of 23-years-old) as a single dose for COVID-19 vaccination. The facility where COVID-19 vaccine was administered was at a hospital and anatomically located on the left arm. Medical history not reported. The patient was not pregnant at the time of vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took Penicillin (MANUFACTURER UNKNOWN) and Codeine (MANUFACTURER UNKNOWN), from unknown dates to unknown dates for unknown indications and experienced allergy. On 30Dec2020 at 07:00PM, the patient experienced severe headache, fatigue, and nausea. The patient did not receive any treatment for the events. The clinical outcome of the events severe headache, fatigue, and nausea was recovered.  It was also reported that since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Diarrhoea, Dizziness, Fatigue, Migraine
Clinical narrative: Lightheaded ness immediately after vaccine About 24 hours later SEVERE diarrhea/urgency. Nausea. Fatigue. Fever 101. Migraine.; Lightheaded ness immediately after vaccine About 24 hours later SEVERE diarrhea/urgency. Nausea. Fatigue. Fever 101. Migraine.; Lightheaded ness immediately after vaccine About 24 hours later SEVERE diarrhea/urgency. Nausea. Fatigue. Fever 101. Migraine.; Lightheaded ness immediately after vaccine About 24 hours later SEVERE diarrhea/urgency. Nausea. Fatigue. Fever 101. Migraine.; Lightheaded ness immediately after vaccine About 24 hours later SEVERE diarrhea/urgency. Nausea. Fatigue. Fever 101. Migraine.; Lightheaded ness immediately after vaccine About 24 hours later SEVERE diarrhea/urgency. Nausea. Fatigue. Fever 101. Migraine.; This is a spontaneous report from a contactable Nurse (the patient). A 30-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number EL0140, expiration date unknown) via an unspecified route of administration on 29Dec2020 at 12:30 PM (at the age of 30-years-old) at an unspecified dose in the right arm for COVID-19 vaccination. The patient's medical history was not reported. No information was reported regarding allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. The patient was administered the vaccine in the hospital. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient answered "yes" when asked to list any other medications she had received within two weeks of vaccination but did not list those medications. The patient stated that she experienced lightheadedness on 29Dec2020  "immediately after vaccine." About twenty-four hours later, on 30Dec2020 at 13:00  she experienced "SEVERE" diarrhea/urgency, nausea, fatigue, fever of 101 and migraine. The patient did not receive any treatment for the events. The clinical outcomes of lightheadedness, severe diarrhea/urgency, nausea, fatigue, fever of 101 and migraine were reported as recovering. The patient underwent lab tests and procedures which included body temperature: 101  on 30Dec2020. It was also reported that since the vaccination the patient had not been tested for COVID-19.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Lightheaded ness immediately after vaccine About 24 hours later SEVERE diarrhea/urgency. Nausea. Fatigue. Fever 101. Migraine.; Lightheaded ness immediately after vaccine About 24 hours later SEVERE diarrhea/urgency. Nausea. Fatigue. Fever 101. Migraine.; Lightheaded ness immediately after vaccine About 24 hours later SEVERE diarrhea/urgency. Nausea. Fatigue. Fever 101. Migraine.; Lightheaded ness immediately after vaccine About 24 hours later SEVERE diarrhea/urgency. Nausea. Fatigue. Fever 101. Migraine.; Lightheaded ness immediately after vaccine About 24 hours later SEVERE diarrhea/urgency. Nausea. Fatigue. Fever 101. Migraine.; Lightheaded ness immediately after vaccine About 24 hours later SEVERE diarrhea/urgency. Nausea. Fatigue. Fever 101. Migraine.; This is a spontaneous report from a contactable Nurse (the patient). A 30-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number EL0140, expiration date unknown) via an unspecified route of administration on 29Dec2020 at 12:30 PM (at the age of 30-years-old) at an unspecified dose in the right arm for COVID-19 vaccination. The patient's medical history was not reported. No information was reported regarding allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. The patient was administered the vaccine in the hospital. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient answered "yes" when asked to list any other medications she had received within two weeks of vaccination but did not list those medications. The patient stated that she experienced lightheadedness on 29Dec2020  "immediately after vaccine." About twenty-four hours later, on 30Dec2020 at 13:00  she experienced "SEVERE" diarrhea/urgency, nausea, fatigue, fever of 101 and migraine. The patient did not receive any treatment for the events. The clinical outcomes of lightheadedness, severe diarrhea/urgency, nausea, fatigue, fever of 101 and migraine were reported as recovering. The patient underwent lab tests and procedures which included body temperature: 101  on 30Dec2020. It was also reported that since the vaccination the patient had not been tested for COVID-19.
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: runny nose after getting the vaccine; This is a spontaneous report from a contactable consumer. An adult male patient, of an unspecified age, received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date (at an unspecified age) as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. It was unknown if the patient received any other vaccines within 4 weeks prior to the vaccination. It was unknown if prior to vaccination, the patient was diagnosed with COVID-19. On an unspecified date, the patient had a runny nose after getting the vaccine. Since the vaccination, it was unknown if the patient had been tested for COVID-19. The clinical outcome of the runny nose after getting the vaccine was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Headache, Myalgia, Nausea
Clinical narrative: Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache; Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache; Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache; Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache; Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache; Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache; Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache; Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache; This is a spontaneous report from a Non-contactable Physician (patient). A 35-years-old female patient (no pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231) , via an unspecified route of administration on 23Dec2020 at first single dose at arm left for covid-19 immunisation.  The patient received the vaccine at hospital. Medical history included migraine, dermatitis atopic.  The patient's concomitant medications were not reported.  The patient experienced Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache on 24Dec2020. No treatment for events. The outcome of events was recovered. No other vaccine in four weeks; No covid prior vaccination; No covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pyrexia, Rash
Clinical narrative: Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache; Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache; Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache; Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache; Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache; Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache; Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache; Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache; This is a spontaneous report from a Non-contactable Physician (patient). A 35-years-old female patient (no pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231) , via an unspecified route of administration on 23Dec2020 at first single dose at arm left for covid-19 immunisation.  The patient received the vaccine at hospital. Medical history included migraine, dermatitis atopic.  The patient's concomitant medications were not reported.  The patient experienced Rash, bilateral paresthesias in hands and feet in stocking glove distribution, fever (Tmax 101), arthralgias, myalgias, nausea, headache on 24Dec2020. No treatment for events. The outcome of events was recovered. No other vaccine in four weeks; No covid prior vaccination; No covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Nausea, Pain in extremity, Tremor
Clinical narrative: Arm soreness; headache; shakiness; nausea; diarrhea; This is a spontaneous report from a contactable other health professional reported for herself. A 31-year-old female patient (not pregnant at time of the report) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EJ1685), intramuscularly on left arm on 30Dec2020 14:30 at single dose for COVID-19 immunization. Facility type Vaccine was reported as Doctor's office/urgent care. Medical history included SVT, neurocardiogenicy syncope, PVCS, known allergies: PCN. Concomitant medications were not reported. The patient experienced arm soreness, headache, shakiness, nausea, diarrhea on 31Dec2020. No treatment was received for the events. The outcome of the events were not resolved.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Hives and rash under armpits, up neck, and in groin area; Hives and rash under armpits, up neck, and in groin area; This is a spontaneous report from a contactable nurse (patient herself). A 42-Year-old female patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140 and expiration date unknown), via an unspecified route of administration at Left arm on 21Dec2020 07:15 AM at single dose for covid-19 immunisation; levothyroxine sodium (SYNTHROID), via an unspecified route of administration from an unknown date at 125ug daily for hypothyroidism. The patient medical history include hypothyroidism. The patient has no known allergies. The patient experienced hives and rash under armpits, up neck, and in groin area on 23Dec2020 with outcome recovered. Events were considered as non-serious with no treatment. The patient has not tested for COVID-19 before or after the vaccination. The action taken in response to the event for levothyroxine sodium was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Night sweats, Pain
Clinical narrative: night sweats; fatigues; muscle aches; chills; sore arm; mild aches; fever; This is a spontaneous report from a contactable nurse (patient). A 45-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on Dec2020 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient is a NP who received his first dose of the Covid19 vaccine last week. He reported a sore arm and mild aches that resolved after 48 hours; then he developed night sweats, fatigues, muscle aches, and 3 days of a fever. He reported the fever has 'broken', but that chills continued along with fatigue. No one else in his household had these symptoms, so he didn't believe them to be infectious. Didn't seem to have any infectious disease symptoms. The outcome of the events sore arm, mild aches, fever was recovered, of the events fatigue and chills was not recovered, of the other events was unknown.   Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: night sweats; fatigues; muscle aches; chills; sore arm; mild aches; fever; This is a spontaneous report from a contactable nurse (patient). A 45-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on Dec2020 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient is a NP who received his first dose of the Covid19 vaccine last week. He reported a sore arm and mild aches that resolved after 48 hours; then he developed night sweats, fatigues, muscle aches, and 3 days of a fever. He reported the fever has 'broken', but that chills continued along with fatigue. No one else in his household had these symptoms, so he didn't believe them to be infectious. Didn't seem to have any infectious disease symptoms. The outcome of the events sore arm, mild aches, fever was recovered, of the events fatigue and chills was not recovered, of the other events was unknown.   Information on the lot/batch number has been requested.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Fatigue, Hypersomnia
Clinical narrative: got a very metallic taste in my mouth; sleep a lot; tired; This is a spontaneous report from a contactable healthcare professional.  A 41-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140/ELO140), via an unspecified route of administration, at the left arm on 30Dec2020 06:30 at a single dose for COVID-19 immunization at a hospital.  Medical history included seasonal allergies and doesn't take medications. On the same day of 30Dec2020, about an hour after vaccination, patient got a very metallic taste in mouth, which lasted for about 12-18 hours and did sleep a lot, which she expected, but woke up about 11 at night and still had it and it was gone. Patient knew she slept longer than she normally does, went to bed at 1PM and slept until 11PM, which is not usually normal. Was up for about an hour or two and then went back to bed until 8AM of 31Dec2020. Patient was concern was if it was some type of reaction that it would mean she was going to have a stronger reaction to the second one and stated it was irritating but not a huge deal. Patient also felt tired and expected it as she worked five 12-hour shifts in a row. Patient was not sure if the metallic taste was connected to the COVID-19 vaccine. No prior vaccinations within 4 weeks. Outcome of the events was unknown.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itching; This is a spontaneous report from a contactable nurse reported for herself. A 38-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231 and expiration date unknown), via an unspecified route of administration on the right upper arm deltoid on 28Dec2020 at single dose for covid-19 immunisation. The patient medical history included Gallbladder removal from 2019 to 2019, asthma but grew out of it which the last time she had an attack was when she was 12 years old, C-sections for her kids. The patient concomitant medications reported as none. The patient was got the COVID vaccine, the first shot and she experienced itching that's why she took the Benadryl 50 mg. She didn't know if that was normal for people who had the covid vaccine to experience this. The vaccine was received on Monday, 28Dec2020 and the itching started Tuesday on 29Dec2020. She was ok on Wednesday 30Dec2020 but today she is itching again. She took Benadryl 50mg the day the itching started, just once and the next day she was fine. It is explained that the itching was not severe and she was not scratching her skin, she just feel itchy like something was crawling on her skin. She has no known allergies but does remember when C sections had for her kids, she had severe itching with the epidural, she experienced this with but it happens every time she gets an epidural. She has had no adverse events or allergic reactions to any other vaccines. The vaccine was administered on the right upper arm deltoid. The outcome of the event was not recovered.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Headache, Injection site pain
Clinical narrative: Chills, muscle/joint pain, headache, injection site pain, fever 103.9; Chills, muscle/joint pain, headache, injection site pain, fever 103.9; Chills, muscle/joint pain, headache, injection site pain, fever 103.9; Chills, muscle/joint pain, headache, injection site pain, fever 103.9; Chills, muscle/joint pain, headache, injection site pain, fever 103.9; Chills, muscle/joint pain, headache, injection site pain, fever 103.9; This is a spontaneous report from a contactable Nurse (Patient). A 53-years-old female patient (no pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number Ej1685) , via an unspecified route of administration on 22Dec2020 11:00 at first single dose at arm left for covid-19 immunisation .  Medical history included iodine allergy.  Concomitant medication included fish oil.  The patient experienced Chills, muscle/joint pain, headache, injection site pain, fever 103.9 on 22Dec2020 21:00. Therapeutic measures were taken as a result of events was Ibuprofen. The outcome of events was recovered with sequelae. No other vaccine in four weeks; No covid prior vaccination; No covid tested post vaccination
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Chills, muscle/joint pain, headache, injection site pain, fever 103.9; Chills, muscle/joint pain, headache, injection site pain, fever 103.9; Chills, muscle/joint pain, headache, injection site pain, fever 103.9; Chills, muscle/joint pain, headache, injection site pain, fever 103.9; Chills, muscle/joint pain, headache, injection site pain, fever 103.9; Chills, muscle/joint pain, headache, injection site pain, fever 103.9; This is a spontaneous report from a contactable Nurse (Patient). A 53-years-old female patient (no pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number Ej1685) , via an unspecified route of administration on 22Dec2020 11:00 at first single dose at arm left for covid-19 immunisation .  Medical history included iodine allergy.  Concomitant medication included fish oil.  The patient experienced Chills, muscle/joint pain, headache, injection site pain, fever 103.9 on 22Dec2020 21:00. Therapeutic measures were taken as a result of events was Ibuprofen. The outcome of events was recovered with sequelae. No other vaccine in four weeks; No covid prior vaccination; No covid tested post vaccination
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain
Clinical narrative: severe hip pain and low back; severe hip pain and low back; This is a spontaneous report from a contactable pharmacist.  A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from 24Dec2020 15:30 to at a single dose, for COVID-19 immunization. Medical history included arthritis in the lumbar region, a slight herniated disc. The patient's concomitant medications were not reported. Two (2) days after vaccination, in the morning of 26Dec2020, he had 'severe hip pain and low back'. It was stated that he did not do anything to flare that up. Also, never had pain in his hips before, and the pain in his back is higher. He has been off work this week due to the pain. Visited ER doctor who provided recommendations including application of heat. It is not getting better. Although with heat it feels better. The outcome of events was recovering.   Follow-up attempts are completed. The following information on the batch number has been requested.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Red, raised, itchy bump at the insertion site that is warm to the touch. I am now over 48 hours since getting the vaccination.; Red, raised, itchy bump at the insertion site that is warm to the touch. I am now over 48 hours since getting the vaccination.; Red, raised, itchy bump at the insertion site that is warm to the touch. I am now over 48 hours since getting the vaccination.; Red, raised, itchy bump at the insertion site that is warm to the touch. I am now over 48 hours since getting the vaccination.; This is a spontaneous report from a non-contactable nurse who reported for herself. A 40-year-old female patient received first single dose of BNT162B2 (Pfizer/BioNTech Covid-19 vaccine, Lot number: EL0140) intramuscularly at right arm at 10:00 AM on 29Dec2020 for Covid-19 immunization. The patient received the vaccine in hospital. The patient had a history of hypothyroidism and had known allergies to sulfa. Concomitant medications in two weeks included Levothyroxine, amlodipine, losartan, drospirenone, ethinylestradiol betadex clathrate (YAZ), tizanadine, montelukast sodium (SINGULAIR), terbinafine (LAMISIL), cetirizine hydrochloride (Zyrtec). At 12:00PM on 29Dec2020, the patient developed red, raised, itchy bump at the insertion site that was warm to the touch. No treatment was received. The events had not resolved at the time of reporting. The reporter considered the events were non-serious.  No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Itching and diffuse hives; Itching and diffuse hives; This is a spontaneous report from a contactable nurse. A 43-year-old female patient received a single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot#: EL0140) as the first dose via intramuscular in the left arm on 30Dec2020 11:45 for COVID-19 immunization. Medical history included multiple allergies. Concomitant medications were not reported. It was unknown whether the patient received any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown whether the patient diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient had itching and diffuse hives on 30Dec2020 12:15. Emergency department (ED) evaluation. Diphenhydramine hydrochloride (BENADRYL) and steroids prescribed. The event was reported as non-serious. The outcome of the events was recovering.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Pain in extremity
Clinical narrative: Arm soreness; headache; fatigue; myalgias; arthralgias; undetectable antibodies; This is a spontaneous report from a contactable nurse (patient). A 37-year-old female patient received a single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot#EK9231) for the first dose via intramuscular in the left arm on 22Dec2020 12:00 for COVID-19 immunization. Medical history included post viral syndrome (COVID) or long COVID from Mar2020. The patient had undetectable antibodies in Apr2020. Concomitant medications included curcuma longa rhizome, piper nigrum fruit (TURMERIC +), colecalciferol (VITAMIN D), cobamamide (VITAMIN B12), bifidobacterium lactis (PROBIOTIC). The patient was diagnosed with COVID-19 prior to vaccination. The patient had no known allergies (NKA). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not tested for COVID-19 since the vaccination. The patient had arm soreness 3 days, 1 headache, fatigue starting from night of injection increasing to requiring 1 hour nap on day 6 and 7, myalgias and arthralgias day 6 and 7; events onset date reported as 22Dec2020. Blood drawn 1 week after injection and the patient had undetectable antibodies in Dec2020, no movement in her CD4 or CD8 in T lymphocyte panel. The events resulted in doctor or other healthcare professional office/clinic visit. Events were reported as non-serious. No treatment was received for the events. The outcome of the events was recovering.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, SARS-CoV-2 antibody test negative
Clinical narrative: Arm soreness; headache; fatigue; myalgias; arthralgias; undetectable antibodies; This is a spontaneous report from a contactable nurse (patient). A 37-year-old female patient received a single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot#EK9231) for the first dose via intramuscular in the left arm on 22Dec2020 12:00 for COVID-19 immunization. Medical history included post viral syndrome (COVID) or long COVID from Mar2020. The patient had undetectable antibodies in Apr2020. Concomitant medications included curcuma longa rhizome, piper nigrum fruit (TURMERIC +), colecalciferol (VITAMIN D), cobamamide (VITAMIN B12), bifidobacterium lactis (PROBIOTIC). The patient was diagnosed with COVID-19 prior to vaccination. The patient had no known allergies (NKA). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not tested for COVID-19 since the vaccination. The patient had arm soreness 3 days, 1 headache, fatigue starting from night of injection increasing to requiring 1 hour nap on day 6 and 7, myalgias and arthralgias day 6 and 7; events onset date reported as 22Dec2020. Blood drawn 1 week after injection and the patient had undetectable antibodies in Dec2020, no movement in her CD4 or CD8 in T lymphocyte panel. The events resulted in doctor or other healthcare professional office/clinic visit. Events were reported as non-serious. No treatment was received for the events. The outcome of the events was recovering.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chills, Headache, Pain, SARS-CoV-2 test
Clinical narrative: Left arm soreness.; Chills and shivering on the night of the vaccine; Severe body aches and back pains; Severe body aches and back pains; Severe headaches; This is a spontaneous report from a contactable physician (patient). A 31-year-old male patient received a single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot# EK923) as the first dose via an unspecified route of administration in the left arm on 29Dec2020 08:00 for COVID-19 immunization. Medical history included test positive for COVID/ diagnosed with COVID-19 from Apr2020. The patient was diagnosed with COVID-19 prior to vaccination. The patient did not have COVID prior vaccination. The patient had no known allergies. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. And the patient did not take any other medications within 2 weeks of vaccination. The patient had COVID test post vaccination in Dec2020(also reported that the patient had not been tested for COVID-19 since the vaccination). The patient had left arm soreness; chills and shivering on the night of the vaccine; severe body aches and back pains; severe headaches; event onset date reported as 30Dec2020 02:00. The patient was tested positive for COVID in Apr2020 and symptoms felt exactly the same. All the events were reported as non-serious. No treatment was received for the events. The outcome of the events was not recovered.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Left arm soreness.; Chills and shivering on the night of the vaccine; Severe body aches and back pains; Severe body aches and back pains; Severe headaches; This is a spontaneous report from a contactable physician (patient). A 31-year-old male patient received a single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot# EK923) as the first dose via an unspecified route of administration in the left arm on 29Dec2020 08:00 for COVID-19 immunization. Medical history included test positive for COVID/ diagnosed with COVID-19 from Apr2020. The patient was diagnosed with COVID-19 prior to vaccination. The patient did not have COVID prior vaccination. The patient had no known allergies. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. And the patient did not take any other medications within 2 weeks of vaccination. The patient had COVID test post vaccination in Dec2020(also reported that the patient had not been tested for COVID-19 since the vaccination). The patient had left arm soreness; chills and shivering on the night of the vaccine; severe body aches and back pains; severe headaches; event onset date reported as 30Dec2020 02:00. The patient was tested positive for COVID in Apr2020 and symptoms felt exactly the same. All the events were reported as non-serious. No treatment was received for the events. The outcome of the events was not recovered.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Generalized lymphadenopathy; This is a spontaneous report from a contactable physician reporting for herself. A 27-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number unknown) on an unspecified date at age of 27 years old (as reported), at a single dose intramuscularly in the left arm, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. No known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced generalized lymphadenopathy on 29Dec2020 06:00 am. The event was non-serious, no treatment received. The patient was recovering from the event.  Information about Lot/Batch number has been requested.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea
Clinical narrative: Tiredness; nausea; headache; chills; This is a spontaneous report from a contactable Other HCP, the patient. A 60-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 26Dec2020 at 13:30 (at the age of 60-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history included migraine. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included omeprazole, montelukast, and vitamin D3, all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Dec2020 at 08:00, the patient experienced tiredness, nausea, headache, and chills. The patient did not receive any treatment for the events. The clinical outcome of the tiredness, nausea, headache, and chills was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: Arm pain at injection site; general body aches; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Lot: EK 5930, intramuscularly on 30Dec2020 11:30 (at the age of 48-years-old), as a single dose in the left arm for COVID-19 immunization. Medical history included penicillin and cephalosporins allergy, possible Behcet's Syndrome, allergies and COVID-19 (diagnosed prior to the vaccination). The patient was not pregnant at the time of vaccination. Concomitant medications were not reported; however, it was reported that the patient received unspecified medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. The patient previously took codeine and experienced allergies. On 30Dec2020 at 20:00 on the second day (as reported), the patient experienced arm pain at the injection site and general body aches. The patient did not receive treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the arm pain at the injection site and general body aches was resolving.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Nausea; Fatigued; chilled; Massive headache; Muscle and joint pain; Muscle and joint pain; This is a spontaneous report from a contactable other HCP (patient). A 55-years-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via intramuscular in left arm on 29Dec2020 10:30 at first single dose for COVID-19 immunization. Medical history included COVID-19. Concomitant medication received within 2 weeks of vaccination included fluoxetine hydrochloride (PROZAC). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient started with muscle and joint pain, within an hour had a massive headache (took ibuprofen). The next day patient began to feel fatigued, chilled, still massive headache, muscle and joint pain and nausea set in the second evening. On 31Dec2020 still had a massive headache but all other symptoms began to fade as the day went on. Currently the evening of the 31Dec2020 still a massive headache. Adverse event start date reported as 29Dec2020 01:15 AM. Events were considered as non-serious. No other treatment received for the adverse events (except ibuprofen). Since the vaccination, the patient had not been tested for COVID-19. Outcome of event headache was not recovered, of other events was recovering.  Information about lot/batch number requested
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Nausea; Fatigued; chilled; Massive headache; Muscle and joint pain; Muscle and joint pain; This is a spontaneous report from a contactable other HCP (patient). A 55-years-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via intramuscular in left arm on 29Dec2020 10:30 at first single dose for COVID-19 immunization. Medical history included COVID-19. Concomitant medication received within 2 weeks of vaccination included fluoxetine hydrochloride (PROZAC). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient started with muscle and joint pain, within an hour had a massive headache (took ibuprofen). The next day patient began to feel fatigued, chilled, still massive headache, muscle and joint pain and nausea set in the second evening. On 31Dec2020 still had a massive headache but all other symptoms began to fade as the day went on. Currently the evening of the 31Dec2020 still a massive headache. Adverse event start date reported as 29Dec2020 01:15 AM. Events were considered as non-serious. No other treatment received for the adverse events (except ibuprofen). Since the vaccination, the patient had not been tested for COVID-19. Outcome of event headache was not recovered, of other events was recovering.  Information about lot/batch number requested
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Lymphadenopathy, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: lymphadenopthy; Injection site pain; joint pain; injection site swelling and redness (about the size of a hard dollar); injection site swelling and redness (about the size of a hard dollar); This is a spontaneous report from a contactable other health professional (other HCP) reported for herself. A 44-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; brand: Pfizer, lot number: EK5730) via an unspecified route of administration at left arm on 30Dec2020 at 01:00 PM, at a single dose (dose number: 1) for COVID-19 immunization. Medical history included known allergies to apples, and no other medical history. The patient was not pregnant. Concomitant medications in two weeks included colecalciferol (VITAMIN D). No other vaccine received on same date. No other vaccine in four weeks. Facility where the most recent COVID-19 vaccine was administered was at hospital. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced adverse events injection site pain, joint pain, lymphadenopthy, injection site swelling and redness (about the size of a hard dollar); all with start date on 30Dec2020 at 05:00 PM. The events were reported as non-serious. No treatment received for events. The outcome of events was not recovered.